Login to Your Account



Indevus Jumps, Endo Slumps on Plans for $637M Merger

By Donna Young


Wednesday, January 7, 2009
Shares of Indevus Pharmaceuticals Inc. soared 73.6 percent Tuesday after the Lexington, Mass.-based company said it was being acquired by Endo Pharmaceuticals Holdings Inc. for $4.50 per share, or about $370 million in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription